Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination drug containing fluocortolone, fluocortolone caproate (also known as fluocortolone hexanoate), and retinoic acid. Fluocortolone and fluocortolone caproate are glucocorticoids known for their anti-inflammatory properties. Retinoic acid is a retinoid that influences cell growth and differentiation. The combination is likely designed to utilize the anti-inflammatory effects of the fluocortolone components alongside the cell-regulating properties of retinoic acid. Information regarding specific approved indications, manufacturers, or clinical trials for this exact three-component combination is limited in the provided search results. When used individually or in other combinations, these components are typically formulated as ointments, creams, or suppositories.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fluocortolone + Fluocortolone Caproate + Retinoic Acid.